First Command Advisory Services’s Moderna MRNA Stock Holding History

First Command Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-850	Closed	-$43.2K	–	1280
2026 Q1	$43.2K	Sell	850 -2	-0.2%	-$93	﹤0.01%	373
2025 Q4	$25.1K	Sell	852 -750	-47%	-$20.4K	﹤0.01%	395
2025 Q3	$41.4K	Hold	1,602	–	–	﹤0.01%	325
2025 Q2	$44.2K	Hold	1,602	–	–	﹤0.01%	298
2025 Q1	$45.4K	Hold	1,602	–	–	﹤0.01%	285
2024 Q4	$66.6K	Hold	1,602	–	–	﹤0.01%	251
2024 Q3	$107K	Hold	1,602	–	–	﹤0.01%	220
2024 Q2	$190K	Sell	1,602 -4	-0.2%	-$506	﹤0.01%	156
2024 Q1	$171K	Buy	1,606 +4	+0.2%	+$403	﹤0.01%	161
2023 Q4	$159K	Hold	1,602	–	–	﹤0.01%	157
2023 Q3	$165K	Buy	+1,602	New	+$179K	﹤0.01%	153

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

First Command Advisory Services's MRNA Position: Q2 2026 in Review

First Command Advisory Services sold out of Moderna (MRNA) in Q2 2026, closing a stake of 850 shares — an estimated $43.2K sold.

First Command Advisory Services first reported a position in MRNA in Q3 2023 and held it in 11 quarters. The position peaked at $190K in Q2 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

First Command Advisory Services reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
First Command Advisory Services sold 850 Moderna shares in Q2 2026, an estimated $43.2K.
First Command Advisory Services first reported a position in Moderna in Q3 2023 and held it in 11 quarters.
First Command Advisory Services's Moderna position peaked at $190K in Q2 2024.
782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.